InVicto ventilator

InVicto Logo DG - 200325 website2.jpg

JFD’s InVicto™ ventilator was designed in response to the COVID-19 pandemic to address the ventilator shortage and minimise oxygen consumption.

It is currently undergoing clinical trials in India, in partnership with Narayana Health. The system is also being evaluated by clinicians in other countries and preparations for global distribution are underway.

The InVicto™ system can support global healthcare services by reducing pressure on intensive care unit facilities.

JFD’s solution is a pressure cycled automatic ventilator system. This is based on a modification of a mechanical ventilator previously used in clinical hyperbaric oxygen treatment of critically ill patients. InVicto™ is a small mechanical device with no moving parts that attaches to a oral-nasal breathing mask, worn by the patient.

Sales enquiry

Commercial off the shelf (COTS) design based on previously qualified hyperbaric oxygen therapy ventilation aid
Gas powered, with no electrical or moving parts; no external power supply required
Portable and multi-location usage
Suitable for delivering FiO2 treatment gas from 21% to 90% oxygen
Can be used via oral-nasal mask
Can be automatic or patient triggered
Mechanical device with no moving parts means reliable operation 24/7 over long periods of continuous operation with intubated patients in critical care

JFD’s Invicto^TM is designed for maximised flexibility of use and many devices can be interfaced with regulated air or oxygen supply source to enable surge capacity. This will enable use in established hospitals, or field hospitals during the COVID-19 pandemic.

Document	Document type	Download
InVicto^TM ventilator system	Datasheet	Datasheet InVicto Ventilator NI UK - 20210217.pdf

Key advantages

Commercial off the shelf (COTS) design based on previously qualified hyperbaric oxygen therapy ventilation aid
Gas powered, with no electrical or moving parts; no external power supply required
Portable and multi-location usage
Suitable for delivering FiO2 treatment gas from 21% to 90% oxygen
Can be used via oral-nasal mask
Can be automatic or patient triggered
Mechanical device with no moving parts means reliable operation 24/7 over long periods of continuous operation with intubated patients in critical care